Eluxadoline is a mixed mu-opioid and kappa-opioid receptor agonist and a delta-opioid receptor antagonist, clinically indicated for the management of diarrhea-predominant irritable bowel syndrome (IBS-D).… Read more



































Eluxadoline is a mixed mu-opioid and kappa-opioid receptor agonist and a delta-opioid receptor antagonist, clinically indicated for the management of diarrhea-predominant irritable bowel syndrome (IBS-D). Because precision in analytical testing is vital for this therapeutic agent, laboratories rely on high-quality reference standards, metabolites, and degradation products to ensure accurate results. This category includes a comprehensive selection of Eluxadoline-related compounds, such as known impurities, N-Boc amino acid derivatives, imidazolyl amines, and glucuronide metabolites, essential for rigorous impurity profiling and method validation. Additionally, the availability of stable isotope-labelled compounds provides a critical tool for quantitative bioanalysis, allowing researchers to effectively correct for matrix effects and instrumental variability during LC-MS/MS procedures. By supporting consistent quality control and development of reliable assay methods, these reference materials facilitate the rigorous scientific standards required throughout the pharmaceutical development and regulatory testing lifecycle.